Xinying Yang

发表

Discovery of potent N-(isoxazol-5-yl)amides as HSP90 inhibitors.

Yechun Xu, Min Huang, M. Geng, 2014, European journal of medicinal chemistry.

Discovery, mechanism and metabolism studies of 2,3-difluorophenyl-linker-containing PARP1 inhibitors with enhanced in vivo efficacy for cancer therapy.

Yun Tang, Yi Chen, Z. Miao, 2017, European journal of medicinal chemistry.

[Effect of EGFR-TKI on lymphangiogenesis of lung cancer with EGFR mutation].

B. Jiang, Fukang Teng, Yan Pan, 2014, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Discovery of 3-(5'-Substituted)-Benzimidazole-5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors: Design, Synthesis, and Biological Evaluation.

C. Luo, M. Geng, Fanwang Meng, 2016, Journal of medicinal chemistry.

Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma

Min Huang, Yi Chen, Jian Ding, 2017, Hepatology.

Discovery of novel 2,4-diarylaminopyrimidine analogues (DAAPalogues) showing potent inhibitory activities against both wild-type and mutant ALK kinases.

Jian Ding, M. Geng, Zilan Song, 2015, Journal of medicinal chemistry.

c-Myc alterations confer therapeutic response and acquired resistance to c-Met inhibitors in MET-addicted cancers.

Min Huang, Yi Chen, Jian Ding, 2015, Cancer research.

Japonicone A Suppresses Growth of Burkitt Lymphoma Cells through Its Effect on NF-κB

Weidong Zhang, Ruiwen Zhang, Jing-quan Li, 2013, Clinical Cancer Research.

Dihydroartemisinin Exerts Its Anticancer Activity through Depleting Cellular Iron via Transferrin Receptor-1

Tao Chen, Hui Wang, Junyang Li, 2012, PloS one.

Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer.

Min Huang, Yi Chen, Jian Ding, 2016, Cancer cell.

Cancer Therapy : Preclinical JaponiconeASuppressesGrowth of Burkitt LymphomaCells through Its Effect on NFk B

Weidong Zhang, Ruiwen Zhang, Jing-quan Li, 2013 .

Experimental Therapy of Ovarian Cancer with Synthetic Makaluvamine Analog: In Vitro and In Vivo Anticancer Activity and Molecular Mechanisms of Action

Ruiwen Zhang, S. Velu, Tao Chen, 2011, PloS one.

Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE.

Zhaohai Wang, Keming Zhang, Yilu Zhang, 2012, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Inhibition of Tumor Lymphangiogenesis is an Important Part that EGFR-TKIs Play in the Treatment of NSCLC

Hongchun Liu, Minghui Cai, Xinying Yang, 2020, Journal of Cancer.

Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models

Yi Chen, Jian Ding, M. Geng, 2017, Molecular Cancer Therapeutics.

Acidic oligosaccharide sugar chain, a marine-derived oligosaccharide, activates human glial cell line-derived neurotrophic factor signaling

M. Geng, Limei Wang, Xue-hong Chen, 2007, Neuroscience Letters.

Tanshinone-1 induces tumor cell killing, enhanced by inhibition of secondary activation of signaling networks

Y. Chen, Z. Miao, Jian Ding, 2013, Cell Death and Disease.

Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity

Min Huang, Jian Ding, M. Geng, 2017, Oncogene.

c-Myc alterations confer therapeutic response and acquired resistance to c-Met inhibitors in MET-addicted cancers.

Min Huang, Yi Chen, Jian Ding, 2015, Cancer research.